Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan

Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan

Introduction To investigate factors affecting glycemic control, oral antidiabetic drug (OAD) treatment distribution and self-care activities among patients with type 2 diabetes mellitus (T2DM) who newly initiate OAD monotherapy in a real-world setting in Japan.Research design and methods A Real-worl...

Full description

Bibliographic Details
Main Authors:	Daisuke Yabe, Hideki Origasa, Hirotaka Watada, Takashi Kadowaki, Iichiro Shimomura, Hiroko Higashiyama, Keisuke Tobe, Kristy Iglay, Shigeru Tokita, Yutaka Seino
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-12-01
Series:	BMJ Open Diabetes Research & Care
Online Access:	https://drc.bmj.com/content/8/2/e001361.full

Similar Items

Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
by: Hideki Origasa, et al.
Published: (2022-12-01)

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
by: Lingfeng Yang, et al.
Published: (2021-08-01)

Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index
by: Daisuke Yabe, et al.
Published: (2022-07-01)

Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference
by: Daisuke Yabe, et al.
Published: (2011-01-01)

Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity
by: Ryota Usui, et al.
Published: (2019-07-01)

Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes
by: Tunceli K, et al.
Published: (2015-01-01)

The Asian Association for the Study of Diabetes: The first 10 years and the next 10 years
by: Yutaka Seino, et al.
Published: (2020-09-01)

Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
by: Kun Ho Yoon, et al.
Published: (2011-02-01)

Long‐term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes
by: Yoshihiro Takahashi, et al.
Published: (2024-01-01)

Preoperative fundus examination in patients with diabetes scheduled for surgery
by: Hirotaka Watanabe, et al.
Published: (2021-08-01)

Changes of HbA1c variability after the switch to a longer‐acting insulin analog in people with type 1 diabetes
by: Hirotaka Watanabe, et al.
Published: (2023-02-01)

Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
by: Hirotaka Watada, et al.
Published: (2021-08-01)

Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of two randomized, placebo‐controlled trials
by: Katsuhiko Hagi, et al.
Published: (2023-09-01)

Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients
by: Noh Y, et al.
Published: (2018-09-01)

Comparison of antidiabetic drugs added to sulfonylurea monotherapy in patients with type 2 diabetes mellitus: A network meta-analysis.
by: Dan Qian, et al.
Published: (2018-01-01)

Effects of physician’s diabetes self‐management education using Japan Association of Diabetes Education and Care Diabetes Education Card System Program and a self‐monitoring of blood glucose readings analyzer in individuals with type 2 diabetes: An exploratory, open‐labeled, prospective randomized clinical trial
by: Nagaaki Tanaka, et al.
Published: (2021-12-01)

Why Are Incretin-Based Therapies More Efficient in East Asians? Perspectives from the Pathophysiology of Type 2 Diabetes and East Asian Dietary Habits
by: Daisuke Yabe, et al.
Published: (2015-11-01)

Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis.
by: Elizabeth S Mearns, et al.
Published: (2015-01-01)

Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes
by: Satomi Wakasugi, et al.
Published: (2021-01-01)

Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER
by: Suzanne V. Arnold, et al.
Published: (2022-04-01)

Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus
by: Takafumi Masuda, et al.
Published: (2024-02-01)

Sleep-wake cycle irregularities in type 2 diabetics
by: Nakanishi-Minami Tomoko, et al.
Published: (2012-05-01)

Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study
by: Tomoya Mita, et al.
Published: (2023-09-01)

Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
by: Jesús Medina, et al.
Published: (2021-08-01)

Understanding of antidiabetic medication is associated with blood glucose in patients with type 2 diabetes: At baseline date of the KAMOGAWA‐DM cohort study
by: Ryosuke Sakai, et al.
Published: (2019-03-01)

Monotherapy in Patients with Type 2 Diabetes Mellitus
by: Sang Youl Rhee, et al.
Published: (2017-10-01)

A Review of Recent Findings on Meal Sequence: An Attractive Dietary Approach to Prevention and Management of Type 2 Diabetes
by: Sodai Kubota, et al.
Published: (2020-08-01)

Oral antidiabetic for the metabolic control in gestational diabetes
by: Yoany Marín Tápanes, et al.
Published: (2016-10-01)

Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
by: Bao Sun, et al.
Published: (2021-01-01)

Association of new loci identified in European genome-wide association studies with susceptibility to type 2 diabetes in the Japanese.
by: Toshihiko Ohshige, et al.
Published: (2011-01-01)

Cardiovascular Outcomes with Finerenone According to Glycemic Status at Baseline and Prior Treatment with Newer Antidiabetics among Patients with Type 2 Diabetes Mellitus
by: Dimitrios Patoulias, et al.
Published: (2022-02-01)

Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes
by: Naohiro Taya, et al.
Published: (2021-05-01)

Aflibercept monotherapy or bevacizumab first for diabetic macular edema
by: Avner Hostovsky, et al.
Published: (2024-01-01)

Predictors of metformin monotherapy failure in gestational diabetes mellitus
by: Vânia Benido Silva, et al.
Published: (2022-05-01)

Correction: Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
Published: (2023-03-01)

Optimizing weight control in diabetes: antidiabetic drug selection
by: S Kalra, et al.
Published: (2010-08-01)

Optimizing weight control in diabetes: antidiabetic drug selection
by: Kalra S
Published: (2010-08-01)

Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus
by: Yasufumi Seki, et al.
Published: (2023-10-01)

Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes
by: Singh AK, et al.
Published: (2021-07-01)

Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE)
by: Naoto Katakami, et al.
Published: (2018-02-01)